The Scientific Advisory Board (SAB) comprises distinguished senior leaders with strong connections to both global and local networks. They bring extensive experience in strategy development and advisory roles, demonstrated through their leadership of major programmes and institutions. The Board offers advice to the NIRBA Executive Director on shaping a strategic vision for NIRBA, informed by emerging scientific trends and collaborative opportunities both globally and locally. Through their engagement, they help elevate the international standing of NIRBA, supporting efforts in talent recruitment and the development of new partnerships.
Professor Michael B. Yaffe is the David H. Koch Professor of Science and Professor of Biology and Biological Engineering at MIT, and Director of the MIT Center for Precision Cancer Medicine. He is also an attending surgeon and intensivist at Beth Israel Deaconess Medical Center, specializing in injury and surgical oncology. Professor Yaffe received his MD-PhD from Case Western Reserve University, completed surgical training at University Hospitals of Cleveland and New England Deaconess Hospital, and specialized in critical care at Harvard Medical School.
A recognized leader in cancer medicine and cell biology, he serves as Scientific Editor-in-Chief of Science Signaling and sits on multiple editorial boards. Professor Yaffe is an elected member of the Association of American Physicians, a MacVicar Faculty Fellow, and a retired Colonel from the U.S. Army Reserve Medical Corps. He is a co-founder and advisor to several biotechnology companies, contributing significantly to translational research and innovation.
Professor Xiang-Dong Fu is Chair Professor of RNA Biology and Regenerative Medicine at Westlake University. Professor Fu received his B.S. in Virology from Wuhan University, his Ph.D. in Biochemistry from Case Western Reserve University, and completed postdoctoral training in Molecular Biology at Harvard University. Before joining Westlake University, he was Distinguished Professor of Cellular and Molecular Medicine at the University of California, San Diego.
Professor Fu is an elected Fellow of the American Association for the Advancement of Science (AAAS), a Searle Scholar, and recipient of the Falling Walls Berlin Science Breakthrough of the Year award. He has also been recognized with the Ray Wu Society Lifetime Achievement Award and the Leukemia and Lymphoma Society Scholar Award. Professor Fu remains highly active in scientific leadership, serving on editorial boards and in professional societies, including as President of the RNA Therapeutics Society of China.
Professor Lynne E. Maquat is the J. Lowell Orbison Endowed Chair and Professor of Biochemistry & Biophysics at the University of Rochester, where she also holds appointments in Pediatrics and Oncology. She is the Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester. Professor Maquat earned her Ph.D. in Biochemistry from the University of Wisconsin-Madison and completed postdoctoral training at the McArdle Laboratory for Cancer Research.
Professor Maquat serves as a scientific advisor to multiple academic institutes and biotech company and is a member of the editorial board for journals in cell biology and RNA biology.
Professor Gene W. Yeo is a Professor of Cellular and Molecular Medicine at the University of California, San Diego (UCSD). He holds a B.Sc. in Chemical Engineering and a B.A. in Economics from the University of Illinois, Urbana-Champaign, a Ph.D. in Computational Neuroscience from MIT, and an MBA from the UCSD Rady School of Management.
Professor Yeo serves on the editorial boards of Cell Reports and Cell Research. His honors include the Alfred P. Sloan Fellowship in Computational Molecular Biology, the International RNA Society Early Career Award, the Lee Kuan Yew Graduate Scholarship, and multiple recognitions for innovation and research leadership. He is a co-founder of several biotechnology companies, including Locana, Eclipse Bioinnovations, Enzerna, and Proteona, and has served on the scientific advisory boards of numerous organizations in the RNA and genomics fields.